Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Oral Findings in a Group of Egyptian Pediatric Patients at Endstage Renal Disease

29 de julio de 2019 actualizado por: Rahma Ali Saber Ali, Cairo University

Oral Findings in a Group of Egyptian Pediatric Patients at Endstage Renal Disease Either on Haemodialysis or After Renal Transplantation

In Egypt, the prevalence of end stage renal disease in pediatric population has never been estimated on a national scale. The patients at end stage renal disease encounter oral and dental problems that emphasize regular and careful screening . In Egypt, the prevalence of oral findings is not studied so we conduct this study to study the oral findings among a group of pediatric patients at end stage renal disease either on haemodialysis or after kidney transplantation.

Descripción general del estudio

Estado

Desconocido

Intervención / Tratamiento

Descripción detallada

Study setting:

  • The study will be held at the center of Pediatric Nephrology and transplantation, El- Mounira children's hospital (Abu El rish).
  • The data collected through the questionnaire will be obtained through an interview between the investigator and the parent or the legal guardian that's based on WHO guide for health surveys(WHO Oral health surveys, 2013)
  • For patients undergoing dialysis, examination will be performed at the dialysis unit during dialysis session (there is no waiting room for patients before dialysis).
  • For patients who received renal transplantation, examination will be performed at the outpatient nephrology clinic during follow up visits.
  • Clinical examination will be performed for both oral (soft tissue) and dental (hard) tissue.
  • Decayed-Missing-Filled Index ( DMF ) which was introduced by Klein, Palmer and Knutson in 1938 and modified by WHO.

The components are:

D component:

Used to describe (Decayed teeth) which include:

Carious tooth. Filled tooth with recurrent decay. Only the roots are left. Defect filling with caries. Temporary filling. Filled tooth surface with other surface decayed.

M component:

Used to describe (Missing teeth due to caries) other cases should be excluded.

F component:

Used to describe (Filled teeth due to caries). Teeth were considered filled without decay when one or more permanent restorations were present and there was no secondary (recurrent) caries or other area of the tooth with primary caries. A tooth with a crown placed because of previous decay was recorded in this category. Teeth stored for reason other than dental caries should be excluded.

deft / defs , which was introduced by Gruebbel in 1944

d- decayed tooth . e- decayed tooth indicated for extraction . f- filled tooth

• The coding system for the Modified DDE Index has three items of information that will be recorded for each tooth surface. (Clarkson and O'Mullane, 1989)

First, the Type of Defect, codes 0-7, was recorded. Then the Sub-type of that defect was noted, i.e., when a demarcated opacity was present, the Sub-type was either white/cream (code 1) or yellow/brown (code 2), or when a diffuse opacity was present, then six options were possible. Finally, the extent of each defect was recorded. The new additional sub-type (code 3) termed "diffuse confluent opacity" is defined as a diffuse opacity in which any patchiness has merged into a regular condensed chalky white area, and it could cover the entire surface of a tooth or be confined to a localized area of the tooth surface.

  • Oral candidiasis assessment will be based on the Lehner scale (Cleverson et al., 2014)
  • In assessing the degree of gingival hyperplasia we will use the index of Angelopoulos and Goaz, described by Prof. T. Djemileva. (Dencheva et al., 2011)

Tipo de estudio

De observación

Inscripción (Anticipado)

150

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

2 años a 14 años (Niño)

Acepta Voluntarios Saludables

N/A

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

All pediatric patients at end stage renal disease attending at the center of Pediatric Nephrology and transplantation, El- Mounira children's hospital (Abu El rish) will be enrolled in the study in a consecutive order according to inclusion criteria.

Descripción

Inclusion Criteria:

  1. Pediatric patients <15 years old with a diagnosis of end stage renal disease "stage 5" receiving dialysis.
  2. Pediatric Patients < 15 years old with kidney transplantation in the monthly follow up.
  3. Recorded data for every patient. (Glomerular Filtration Rate, Creatinine level, urea level and calcium level).

Exclusion Criteria:

  1. Patients undergoing renal dialysis for reasons other than chronic kidney disease, such as acute renal failure secondary to accidents, trauma, snake poisoning.
  2. Patients undergoing peritoneal dialysis.
  3. Patients not physically able to participate in the examination.
  4. Chronic kidney disease patients at stage 2, 3 and 4.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Heamodialysis group
The data will be collected through a questionnaire that will be obtained through an interview between the investigator and the parent or the legal guardian
Kidney transplantation group
The data will be collected through a questionnaire that will be obtained through an interview between the investigator and the parent or the legal guardian

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Caries
Periodo de tiempo: Five minutes
Clinical examination will be done and Caries index will be used ,Unit is the tooth to determine if there is caries or not
Five minutes

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Enamel hypoplasia
Periodo de tiempo: Ten minutes
Clinical examination will be done on each patient to assess enamel hypoplasia and recorded by use of Modified Developmental Defect of Enamel (DDE) Index
Ten minutes
Oral candidiasis
Periodo de tiempo: Five minutes
Clinical examination will be conducted to assess oral candidiasis and recorded by use of Lehner Oral Candidiasis Classification
Five minutes
Gingival overgrowth
Periodo de tiempo: Five minutes
Clinical examination will be done to asess gingival overgrowth and recorded by use of Angelopoulos and Goaz index
Five minutes

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Anticipado)

1 de noviembre de 2019

Finalización primaria (Anticipado)

1 de diciembre de 2019

Finalización del estudio (Anticipado)

1 de enero de 2020

Fechas de registro del estudio

Enviado por primera vez

29 de junio de 2018

Primero enviado que cumplió con los criterios de control de calidad

16 de julio de 2018

Publicado por primera vez (Actual)

18 de julio de 2018

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

31 de julio de 2019

Última actualización enviada que cumplió con los criterios de control de calidad

29 de julio de 2019

Última verificación

1 de julio de 2019

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

3
Suscribir